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Dietary Fat Intake and Endogenous Sex Steroid Hormone
Leve ls in Postmenopausal Women
By Michelle D. Holmes, Donna Spiegelman, Walter C. Willett, JoAnn E. Manson, David J. Hunter, Robert L. Barbieri,
Graham A. Colditz, and Susan E. Hankinson
Purpose: To examine the relationship between
plasma levels of reproductive sex steroid hormones in
postmenopausal women and their reported fat intake.
Methods: We measured plasma sex steroid hor-
mones levels in plasma collected in 1989 and 1990 from
381 healthy postmenopausal women. For each woman,
we measured fat intake in 1986 and 1990 by a food-
frequency questionnaire. The cross-sectional associations
between the percentage of energy from total and specific
types of dietary fat intake and plasma hormone levels
were assessed by linear regression, controlling for en-
ergy intake, obesity, and protein intake.
Results: The plasma estradiol level was 4.3% lower
(95% confidence limits, 28.3%, 20.2%) for a substi-
tution of 5% of energy from fat intake for an equiva-
lent amount of energy from carbohydrate when ad-
justed for obesity and other covariates. Estradiol was
also inversely associated with all other fat types
except trans fat; the inverse associations with vege-
table fat and marine omega-3 fats were statistically
significant.
Conclusion: We observed an inverse association be-
tween total fat intake averaged over 4 to 5 years and
estradiol levels. This result is inconsistent with the hy-
pothesis that fat intake predisposes to breast cancer
risk by raising endogenous estrogen levels.
J Clin Oncol 18:3668-3676. © 2000 by American
Society of Clinical Oncology.
ENDOGENOUS reproductive hormones have beenstrongly implicated in the etiology of breast cancer;
most studies in postmenopausal women show increased risk
with elevated estrogen levels.1,2 On the basis of animal
studies,3,4 international comparisons,4-6 and a meta-analysis
of case-control studies,7 high intake of total dietary fat has
been postulated to increase breast cancer risk. The fact that
a large randomized trial, the Women’s Health Initiative, is
attempting to lower breast cancer risk with a low-fat diet
attests to the appeal of this hypothesis.
However, mechanisms by which high intake of dietary fat
could increase breast cancer risk have not been established.
If high dietary fat intake were to increase estrogen levels,
this would provide a plausible mechanism. In a recent
meta-analysis of metabolic studies, significantly lower es-
tradiol levels were found in the low-fat intervention
groups.8 However, most of the component studies in the
meta-analysis had no concurrent control group and were
confounded by weight loss in the intervention group.9
Prospective studies of dietary fat and breast cancer, which
unlike case-control studies are not prone to recall bias, do
not support the dietary fat hypothesis.10-12 For a protective
effect to be evident, some authors have suggested that fat
intake must account for # 20% of energy. These authors
maintain that such a protective effect has not been found in
cohort studies because they were conducted in Western
populations, in whom the level of fat intake is rarely this
low.4 In a pooled analysis of seven international cohorts
with nearly 5,000 breast cancer cases, the multivariate
relative risk for consuming less than 20% of energy from fat
compared with consuming 30% to 35% of energy from fat
was 1.06 (95% confidence interval, 0.83 to 1.37).11 In
addition, in 14 years of follow-up of the Nurses’ Health
Study (NHS) using a diet assessed at four different times,
we found a 15% greater risk of breast cancer in women who
consumed # 20% of energy from fat than in those who
consumed 30% to 35% of energy from fat. Although this
increased risk was not statistically significant, the overall
linear trend for higher risk with lower fat intake was P (for
trend) 5 .03.12 In this study, we examined the relationship
between plasma levels of reproductive sex steroid hormones
in 381 postmenopausal women on the basis of data collected
in 1989 and 1990 and their reported fat intake, averaged
over two dietary assessments made in 1986 and 1990.
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METHODS
NHS Subjects and Blood Sample Collection
In 1976, the NHS cohort was established when 121,700 female
registered nurses from across the United States, aged 30 to 55 years,
answered a mailed questionnaire on risk factors for cancer and
cardiovascular disease. Every 2 years since, we have sent follow-up
questionnaires to NHS participants. For this analysis, information on
height and age at menarche was assessed in 1976 and on weight at the
age of 18 in 1980. Information on parity and participant’s age at the
birth of the participant’s first child was last assessed in 1984, when
participants were $ 38 years of age. Information on age at menopause,
smoking status, weight change since the age of 18, family history of
breast cancer, and personal history of benign breast disease was
assessed in 1990. Physical activity was also measured in 1990 by a
validated and reproducible questionnaire13 that requested self-report of
weekly leisure time activity estimated for the past year. Scores were
calculated in Metabolic Equivalent Task (MET) hours per week, with
one MET-hour defined as the energy expended in sitting quietly for one
hour. Higher MET values for other activities reflect multiples of energy
expenditure needed for sitting quietly; for example, 10 MET-hours
would represent 21⁄2 hours of brisk walking.
Blood samples were collected in 1989 and 1990 from 32,826 NHS
participants who were from 43 to 69 years of age at the time, as
previously detailed.14 Each woman was sent a kit that contained all
supplies needed for blood collection, plus a supplemental questionnaire
about menopausal status, recent postmenopausal hormone use, time
since last meal, and time of day of blood sampling. Participants
arranged to have their blood drawn and then mailed the whole-blood
sample cooled with an enclosed ice pack via overnight mail. We have
previously documented the stability of the hormones during the period
of transport.15 After receipt in our laboratory, samples were centri-
fuged, divided, and frozen in the vapor phase of liquid nitrogen freezers
(2130°C or colder). Hormone levels for the plasma samples used in
this analysis were assayed in three batches between February and
September 1993. This study was approved by the Institutional Review
Board of the Brigham and Women’s Hospital, Boston, MA.
Women included in this analysis were control subjects in a nested
case-control study of plasma hormone levels and breast cancer risk.16
In addition, 49 women who had reported low fat intake (, 25% and ,
19% of energy on the 1986 and 1990 food-frequency questionnaires
[FFQs], respectively) were added to increase the range of fat intake.
These cut points were chosen to maximize the number of women with
low fat intakes on both questionnaires, and all women who met these
criteria were included in this analysis. These samples were interspersed
with the control samples and were assayed at the same time. Women
included were all postmenopausal (no menses for at least 12 months
before blood sampling) and had not used hormones for at least 3
months before the blood collection. Participants had no previously
diagnosed cancer (except nonmelanoma skin cancer) and could not
have implausible scores for total energy intake (, 500 kcal or . 3,500
kcal/d).
Semiquantitative FFQs
In 1980, a 61-item FFQ designed to assess dietary intake was added
to the biennial NHS questionnaire. In 1984, 1986, and 1990, an
expanded FFQ was used. The FFQs have been described in detail, and
their validity and reproducibility have been documented elsewhere.17,18
The percentage of total energy intake accounted for by fat intake was
calculated, including alcohol intake in total energy. In this analysis,
nutrient intake from the 1986 and the 1990 FFQs were averaged for
each woman; for the 0.8% of women who did not fill out the 1986 FFQ,
only the 1990 values were used.
Laboratory Analysis
Except for estrone sulfate, all hormones were analyzed at the Nichols
Institute (San Juan Capistrano, CA) by radioimmunoassay. The first
two batches of estrone sulfate were assayed by C. Longcope, Univer-
sity of Massachusetts Medical School, and the third batch at Nichols
Institute. Details of the laboratory methods have been previously
reported.16
In each batch of samples, we assessed laboratory precision by the
inclusion of replicate samples unidentifiable to laboratory personnel.
Within-batch laboratory coefficients of variation ranged from 6%
(percentage bioavailable estradiol) to 13.6% dehydroepiandrosterone
(DHEA).16
Statistical Analysis
Statistical analyses were performed with SAS software (SAS Insti-
tute, Cary, NC). First, the distribution of levels for each hormone was
determined. We excluded zero to nine women per hormone whose
values were greater than the absolute value of the 75th percentile plus
three times the interquartile range. Adjusted geometric least squares
mean hormone levels across categories of fat were calculated by
regressing the natural logarithm of hormone levels on potential con-
founders, adding the mean log hormone level to the average of the
residuals, and exponentiating this value. These mean hormone levels
were the predicted levels at the reference values of the confounders.
The association between the percentage of energy from fat intake
and hormone levels was also assessed by linear regression. The robust
variance was used to ensure valid inference even if the regression
residuals were not normally distributed.19 Four-knot restricted cubic
spline models for the regression of hormone levels on percentage of
energy from type of fat, adjusted for other covariates, were used to
examine linearity.20 These models were compared with those that
assumed a linear association to obtain a likelihood ratio test for
nonlinearity. In linear regression, the difference in plasma hormone
levels was modeled on the natural logarithm scale. Solving (1-ebD) 3
100, where b is the estimated regression slope and D is the specified
incremental difference in fat intake, represents the percentage differ-
ence in that hormone level. The effect of total fat and types of fat were
expressed as an incremental increase in percentage of energy from fat.
That increment was 5% of energy for total fat, (animal, vegetable,
saturated, monounsaturated, and polyunsaturated fats), 1% of energy
for trans-unsaturated fat, and 0.01% of energy for omega-3 fats from
fish.
A secondary analysis was performed to determine whether results
could be attributed to a few points having undue influence. In these
linear regressions, dfbetas, which approximate the change in the beta
coefficient that would result from deletion of the observation from the
data set, were calculated for each observation. Participants were
omitted whose dfbeta for the multivariate adjusted slope of hormone
levels on percentage of energy from fat type was greater than the
absolute value of the median dfbeta plus or minus three times the
interquartile range of the dfbetas.21
RESULTS
Characteristics of the 381 women included in the study
are listed in Table 1. The mean age was 62.6 years, mean
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height 64.4 in, and mean body mass index in 1990 25.7
kg/m2. They consumed an average of 1,750 kcal per day,
including 6.8 g of alcohol, 74 g of protein, and 20 g of fiber.
The average percentage of energy intake from fat was 29%
(range, 10% to 46%), which reflects the oversampling of
women with low fat intake. Of total fat intake, 55% was
from animal fat and 45% from vegetable fat. The mean
percentage of energy intake from carbohydrates was 51%.
Fourteen percent had a first-degree family history of breast
cancer, 36% had a personal history of benign breast disease,
and 13% were current smokers.
The 49 women who had been selected for low fat intake
had an average of 17% of energy intake from fat. Compared
with other women, they consumed more fiber (27 v 19
energy-adjusted grams per day) and more carbohydrates
(percentage of energy intake, 65% v 48%). They also had a
lower body mass index in 1990 (23.7 v 26.0 kg/m2) and had
gained less since the age of 18 (6 v 15 kg). There were no
other statistically significant differences between the two
groups in other factors listed in Table 1. Median plasma
hormone levels, along with the tenth to the ninetieth
percentile range, are listed in Table 2.
Table 3 shows the estimated geometric mean of plasma
hormone levels across categories of fat intake at the refer-
ence level of all covariates. The mean levels of andro-
stenedione and DHEA seemed to increase, and the mean
levels of estradiol seemed to decrease in a somewhat linear
fashion across categories of increasing fat intake.
In the multivariate models in Tables 4, 5, and 6, the
inclusion of total energy and protein intake in each model
means that the coefficient for fat can be interpreted as
substitution of a percentage of energy from fat for an equal
percentage of energy from carbohydrates. Table 4 shows the
adjustments for age and energy for each hormone and the
multivariate linear relationship between plasma hormone
levels and percentage of energy intake from fat. In models
adjusted only for age and total energy intake, fat intake was
positively associated with higher levels of all hormones and
inversely associated with sex hormone–binding globulin
(SHBG). Models adjusted only for age were similar.
However, many results were reversed in the multivariate
models. The association of fat intake with levels of SHBG
was positive although not statistically significant. For a 5%
increase in energy from total fat intake, plasma estradiol
level was 4.3% lower (95% confidence limits [CL], 28.3%,
20.2%). Bioavailable estradiol level, bioavailable estradiol
percentage, free estradiol percentage, estrone sulfate level,
and testosterone level were also inversely associated with
total fat intake, although the linear associations were not
statistically significant.
This reversal of association was caused mainly by control
for measures of obesity: body mass index at the age of 18
and weight gain since the age of 18. In a multivariate model
not adjusted for obesity, a 5% increase in energy from total
fat had a nonsignificant positive association with estradiol
level, 0.3% (95% CL, 24.2, 4.9). However, in a model that
contained as the only covariates age, energy, and obesity, a
5% increase in energy from fat was negatively associated
with estradiol level, 22.3% (95% CL, 26.1, 1.6). Results
for bioavailable estradiol level, estradiol free percentage,
estrone level, SHBG level, and testosterone level were
similar.
Table 1. Characteristics of Postmenopausal Women Included in a Study
of Dietary Fat Intake and Endogenous Sex Steroid Hormone Levels
Characteristic Mean 6 SD
Age, years 62.6 6 4.7
Height, in 64.4 6 2.5
Body mass index at the age of 18 years, kg/m2 21.5 6 2.9
Body mass index in 1990, kg/m2 25.7 6 4.5
Change in weight since the age of 18 years, kg 13.4 6 17.0
Age at menarche, years 12.4 6 2.1
Parity 3.4 6 2.0
Age at first birth, years (among 347 parous women) 25.0 6 4.5
Age at menopause, years (among 285 women with natural
menopause)
50.4 6 4.2
Level of physical activity, MET-hours/wk 23.0 6 24.2
Average energy intake, 1986 1 1990, kcal/d 1750 6 443
Average alcohol intake, 1986 1 1990, g/d 6.8 6 10.9
Average protein intake, 1986 1 1990, energy-adjusted g/d 74.1 6 12.8
Average fiber intake, 1986 1 1990, energy-adjusted g/d 19.7 6 6.4
Average percentage of energy from fat, 1986 1 1990 28.8 6 6.7
Average percentage of energy from carbohydrate, 1986 1
1990
50.5 6 8.6
NOTE. Total no. of participants 5 381. Some characteristics are based on
fewer women because of missing values.
Table 2. Plasma Hormone Levels in Postmenopausal Women in a Study
of Dietary Fat Intake and Endogenous Sex Steroid Hormone Levels
Hormone
No. of
Participants Median 10th-90th Percentile
Estradiol, pg/mL 371 7 4-15
Bioavailable estradiol, pg/mL 366 1.5 0.6-4.4
Bioavailable estradiol, % 375 22.6 11.9-37.3
Free estradiol, % 371 1.5 1.3-1.8
Estrone, pg/mL 368 28 16-48
Estrone sulfate, pg/mL 349 190 91-412
SHBG, nmol/L 290 45.7 20.7-83.6
Androstenedione, ng/dL 335 57 29-108
Testosterone, ng/dL 335 22 11-40
DHEA, ng/dL 312 193 87-375
DHEAS, mg/dL 335 75 30-165
Abbreviations: SHBG, sex hormone–binding globulin; DHEA, dehydroepi-
androsterone; DHEAS, DHEA sulfate.
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Fiber intake was not directly associated with hormone
levels in this study. However, dietary fiber may modify the
association between fat intake and hormone levels, with the
greatest inverse association seen in women having the
lowest fiber intake. The change in estradiol levels associated
with a 5% of energy increase in fat intake across tertiles
(lowest to highest) of energy-adjusted fiber intake were
214.5% (95% CL, 219.1, 29.7), 1.5% (26.6, 10.4), and
2.9% (26.4, 1.3) (P [for the interaction term] 5 .25).
Results were similar for bioavailable estradiol and estrone
sulfate levels.
Tables 5 and 6 are similar to Table 4 except that the
relationship between intake of specific types of fat and
plasma hormone levels is examined. In each table, all the
major types of fat that make up total fat intake are included
in the same model; therefore, the estimated effect of each
type of fat can be interpreted as a substitution for an
equivalent amount of energy from carbohydrates, holding
all other aspects of the data constant.
Table 5 shows the relationship of plasma hormone levels
with animal and vegetable fat intake. Estradiol level remained
inversely associated with both animal and vegetable fat intake,
and the linear association with vegetable fat intake was
statistically significant (P 5 .03). SHBG level remained
positively associated with animal fat intake (P 5 .02).
In Table 6, which examines saturated, monounsaturated,
polyunsaturated, trans-unsaturated, and omega-3 (from fish)
fat intake, estradiol level remained inversely associated with
intake of all fat types except trans fats; the linear association
with omega-3 fats from fish was statistically significant.
Estrone level also had a statistically significant inverse
association with omega-3 fats from fish. Strong relation-
ships were seen between some types of fat and some of the
androgens. Polyunsaturated fat intake was inversely associ-
ated with androstenedione, testosterone, DHEA, and dehy-
droepiandrosterone sulfate (DHEAS): a 5% higher energy
intake from polyunsaturated fat was associated with 19% to
46% lower plasma levels of these hormones. In addition, a
5% higher energy intake from monounsaturated fat was
associated with a 35% higher plasma level of DHEA and
DHEAS.
The expression of a linear relationship can be distorted by
a few influential points. The linear regressions in Tables 4
and 6 were repeated using the procedure for deletion of
influential points reported in Statistical Methods. In each
model, an average of 8% of the points (range, 3% to 13%)
were removed for undue influence. All results remained
substantially the same.
DISCUSSION
We observed inverse associations between reported di-
etary intake of total fat averaged over 4 years and five
plasma estrogens and testosterone when adjusted for obesity
and other covariates; this association was statistically sig-
nificant for estradiol. Estradiol level, as well as estrone
sulfate, estrone, and DHEAS levels, has been positively
associated with breast cancer risk in this population.16
Therefore, the present results are contrary to the hypothesis
Table 3. Estimated Geometric Mean of Plasma Hormone Levels Across Categories of Percentage of Energy From Fat
Hormone
Percentage of Energy From Fat
# 15%
(n 5 9)
15.1%-20%
(n 5 49)
20.1%-25%
(n 5 41)
25.1%-30%
(n 5 88)
30.1%-35%
(n 5 132)
35.1%-40%
(n 5 51)
. 40%
(n 5 11)
Estradiol, pg/mL 8.3 7.2 7.7 7.1 7.4 6.9 5.4
Bioavailable estradiol, pg/mL 2.0 1.5 1.7 1.5 1.5 1.6 1.1
Bioavailable estradiol, % 25 22 23 22 21 22 19
Free estradiol, % 1.6 1.6 1.5 1.5 1.5 1.5 1.4
Estrone, pg/mL 28 24 29 29 30 28 23
Estrone sulfate, pg/mL 174 191 185 194 189 174 147
SHBG, nmol/L 47 33 39 46 43 43 61
Androstenedione, ng/dL 45 41 54 59 56 60 69
Testosterone, ng/dL 22 18 20 23 22 20 23
DHEA, ng/dL 130 147 187 192 194 191 215
DHEAS, mg/dL 58 60 62 82 74 77 80
NOTE. Adjusted for the following: age (# 50, 51-55, 56-60, 61-65, . 65 years), laboratory batch (three batches), time of day of blood draw (7 AM-9 AM, 10
AM-12 PM, 1 PM-3 PM, 4 PM-6 AM, missing), age at menopause (, 45, 45-52, $ 53 years), smoking status (never, current, past), body mass index at the age of 18
years (, 19, 19-20.9, 21-22.9, $ 23 kg/m2), weight change since the age of 18 years (, 22, 22 to 2, 2.1 to 5, 5.1 to 10, 10.1 to 20, 20.1 to 25, . 25 kg),
total energy and protein intake (quintiles), alcohol intake (0, 0.1 to 4.9, 5 to 14.9, $ 15 g/d), level of physical activity (, 4, 4 to 11.9, 12 to 24.9, $ 25 MET
hours per week), family history of breast cancer (yes/no), history of benign breast disease (yes/no), parity and age at first birth (nulliparous, one to two births and
age , 25 years, one to two births and age 25 to 29 years, one to two births and age $ 30 years, three to four births and age , 25 years, three to four births
and age 25 to 29 years, three to four births and age $ 30 years, five to eight births and age , 25 years, five to eight births and age $ 25 years), age at menarche
(# 12, 13, $ 14 years), and height (, 63, 63 to 63.9, 64 to 65.9, $ 66 in).
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that high fat intake predisposes to breast cancer risk by
raising endogenous estrogens. They are, however, consis-
tent with our previously reported finding of a modest
inverse relationship between total fat intake and breast
cancer risk.12
The inverse association between fat intake and hormone
levels that we observed depended primarily on control for
obesity. It is important to examine this issue critically. If
obesity were an intermediate step between high fat intake
and elevated hormone levels (ie, high fat intake leads to
obesity, and increased adipose tissue leads to higher hor-
mone levels), then adjustment for obesity would not be
appropriate. However, if obesity is independently associated
with both fat intake and hormone levels (possibly because
health-conscious women restrict both fat intake and total
energy) and not an intermediary, then it is a confounder and
should be adjusted for.
We examined the cross-sectional association between
dietary fat intake (assessed in 1980 and updated in 1984,
1986, and 1990) and body mass index from 1980 through
1994 in the NHS. We used regression methods for clustered
data, because this analysis was based on 415,077 observa-
tions in 85,804 women.22 We adjusted for the following
factors found to be associated with obesity in a previous
study23: smoking status, race, marital status, level of phys-
ical activity, parity, body mass index at age 18, alcohol use,
and total energy intake. We additionally adjusted for protein
intake to determine the association of body mass index with
substituting carbohydrate for fat intake.
Cross-sectionally, women who consumed a higher per-
centage of total energy from fat in this cohort were slightly
(0.08 kg/m2) heavier (95% confidence interval, 0.07 to 0.09;
P [for a linear association] # .0001) per 5% increment in
energy consumed from fat.
We also conducted a longitudinal analysis with 450,013
observations using similar methods in the same women. We
examined how the percentage of energy from fat intake,
cumulatively averaged and updated over time, predicted the
change in body mass index over the next 2-year period.
Longitudinally, fat intake did not predict any increase in
body mass index. An increment of 5% of energy in dietary
fat was associated with 20.003 kg/m2 in body mass index
(95% CL, 20.005, 20.001; P [for an inverse linear asso-
ciation] 5 .02).
Thus, this cross-sectional association seen between fat
intake and body mass index is probably a result of con-
founding by health consciousness: women who strive to be
lean because they believe it to be healthy also consume a
lower fat diet because they have been told that it is healthy.
This lack of association between dietary fat and body fat is
also consistent with randomized trials that have lasted 1
year or longer.24
Because fat intake does not predict weight gain over time
in this cohort, obesity does not seem to be an intermediary
between fat intake and hormone levels, and there is no
reason not to adjust for obesity. Because obesity is associ-
ated cross-sectionally with fat intake in this cohort and is
also associated with hormone levels,14 it is a confounder
and should be adjusted for. For these reasons, we believe
Table 4. Estimated Percentage Difference in Plasma Hormone Levels
From Substituting 5% of Energy From Fat Intake for the Equivalent Amount
of Energy From Carbohydrate Intake
Hormone
% Difference in
Hormone Level
95% CL
%
Estradiol
Age and energy 2.8 21.3, 7.1
Multivariate without BMI 0.3 24.2, 4.9
Age, energy, and BMI 22.3 26.1, 1.6
Multivariate 24.3 28.3, 20.2*
Bioavailable estradiol
Age and energy 8.6 2.3, 15.2*
Multivariate 24.9 210.6, 1.2
Bioavailable estradiol %
Age and energy 4.6 0.9, 8.4*
Multivariate 21.9 25.5, 2.0
Free estradiol %
Age and energy 0.7 20.5, 1.9
Multivariate 20.8 22.0, 0.3
Estrone
Age and energy 3.2 20.3, 6.9
Multivariate 0.3 23.1, 3.8
Estrone sulfate
Age and energy 1.6 22.7, 6.1
Multivariate 23.5 27.9, 1.1
SHBG
Age and energy 23.5 29.5, 2.9
Multivariate 2.9 22.9, 9.1
Androstenedione
Age and energy 4.0 20.2, 8.4
Multivariate 1.3 24.8, 7.7
Testosterone
Age and energy 0.1 26.1, 6.7
Multivariate 22.6 28.7, 3.9
DHEA
Age and energy 3.0 21.9, 8.1
Multivariate 1.6 25.4, 9.2
DHEAS
Age and energy 6.2 0.6, 12.0*
Multivariate 2.0 26.2, 11.0
NOTE. Multivariate models were adjusted for the following: age, laboratory
batch, time of day of phlebotomy, age at menopause, smoking status, body
mass index at the age of 18 years, weight change since the age of 18 years,
total energy intake, protein intake, alcohol intake, physical activity level, family
history of breast cancer, history of benign breast disease, parity, age at first
birth, age at menarche, and height.
Abbreviation: BMI, body mass index.
*P (for linear association) # .04.
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that the multivariate associations of fat intake with hor-
mones, including adjustment for obesity, are the appropriate
ones to examine. We note, however, that even when we did
not adjust for obesity, the association between dietary fat
and estrogen levels was essentially null rather than signifi-
cantly positive.
Previously, the association of dietary fat and endogenous
estrogens has been examined in short-term interventions in
Table 6. Percentage Difference in Plasma Hormone Levels Predicted by Substituting Intake of Fat Types, Mutually Adjusted for Each Other and Other
Covariates for an Equivalent Amount of Energy from Carbohydrates
Hormone
Fat Type
Saturated Monosaturated Polyunsaturated Trans-unsaturated Omega-3 from Fish
Percentage
Difference
in Hormone
Level
95% CL
%
Percentage
Difference
in Hormone
Level
95% CL
%
Percentage
Difference
in Hormone
Level
95% CL
%
Percentage
Difference
in Hormone
Level
95% CL
%
Percentage
Difference
in Hormone
Level
95% CL
%
Estradiol 29.5 224.1, 7.9 20.9 219.7, 22.4 222.1 239.3, 0.1 7.3 27.7, 24.8 20.8* 21.4, 20.2
Bioavailable estradiol 215.0 234.4, 10.2 2.2 226.3, 41.9 223.8 248.1, 12.0 15.0 26.9, 42.0 20.7 21.6, 0.1
Bioavailable estradiol % 27.9 222.9, 9.9 20.1 219.8, 24.6 22.8 223.7, 23.7 8.6 23.9, 22.8 20.2 20.8, 0.3
Free estradiol % 0.7 24.4, 6.1 20.4 27.2, 6.9 23.7 211.3, 4.7 20.5 26.1, 5.5 0 20.1, 0.1
Estrone 0.2 212.8, 15.0 0.5 214.2, 17.7 213.4 229.6, 6.6 4.7 27.7, 18.8 20.6† 21.0, 20.1
Estrone sulfate 2.7 215.0, 24.0 211.2 230.8, 14.0 23.0 228.8, 32.1 0 216.1, 19.2 0.1 20.6, 0.7
SHBG 11.8 29.1, 37.5 6.6 217.7, 38.0 221.2 241.8, 6.8 25.6 219.7, 11.1 0.3 20.4, 1.0
Androstenedione 10.3 212.7, 39.3 4.1 217.7, 31.7 219.3 240.7, 9.9 6.8 210.3, 27.0 0.4 20.3, 1.0
Testosterone 25.3 225.2, 20.0 6.9 217.7, 38.8 230.1‡ 250.2, 21.7 3.5 212.8, 22.9 20.4 21.1, 0.3
DHEA 25.5 227.1, 22.5 35.2 22.9, 88.3 238.5§ 258.5, 29.0 5.0 213.4, 27.3 0.5 20.2, 1.3
DHEAS 28.5 233.4, 25.8 34.7 28.2, 97.7 245.5\ 264.6 216.1 6.1 215.3, 32.9 0.2 20.7, 1.0
NOTE. Values were adjusted for age, laboratory batch, time of day of phlebotomy, age at menopause, smoking status, body mass index at the age of 18 years,
weight change since the age of 18 years, total energy intake, protein intake, alcohol intake, physical activity level, family history of breast cancer, history of benign
breast disease, parity, age at first birth, age at menarche, and height. Increment for saturated fat, polyunsaturated fat, and monounsaturated fat was 5% of energy,
for trans-unsaturated fat 1% of energy, and for omega-3 fats from fish 0.1% of energy.
*P, test for linear association, 5 .02.
†P 5 .007.
‡P 5 .04.
§P 5 .01.
\P 5 .003.
Table 5. Estimated Percentage Difference in Plasma Hormone Levels From Substituting 5% of Energy From Animal Fat or Vegetable Fat, Mutually
Adjusted for Each Other and Other Covariates, for an Equivalent Amount of Energy From Carbohydrates
Hormone
Animal Fat Vegetable Fat
Percentage
Difference in
Hormone
Level
95% CL
%
Percentage
Difference in
Hormone
Level
95% CL
%
Estradiol 22.6 28.4, 3.6 26.4* 211.3, 21.1
Bioavailable estradiol 25.2 213.1, 3.5 25.0 212.1, 2.8
Bioavailable estradiol % 23.8 28.8, 1.5 20.2 24.8, 4.7
Free estradiol % 20.1 22.2, 1.6 21.6 23.5, 0.2
Estrone 2.1 22.7, 7.3 21.7 26.3, 3.0
Estrone sulfate 23.8 210.1, 3.1 23.4 29.8, 3.6
SHBG 9.1* 1.7, 17.0 22.8 29.4, 4.4
Androstenedione 4.6 23.9, 13.9 22.2 29.0, 5.0
Testosterone 0.7 27.2, 9.2 26.1 213.5, 2.0
DHEA 5.7 23.7, 16.0 23.3 211.5, 5.6
DHEAS 5.8 25.3, 18.1 22.6 212.2, 8.1
NOTE. Values were adjusted for age, laboratory batch, time of day of phlebotomy, age at menopause, smoking status, body mass index at the age of 18 years,
weight change since the age of 18 years, total energy intake, protein intake, alcohol intake, physical activity level, family history of breast cancer, history of benign
breast disease, parity, age at first birth, age at menarche, and height.
*P (for linear association) # .03.
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which women were fed a low-fat diet and their plasma
hormones were measured. In a recent meta-analysis of the
results from 13 interventions, including four among post-
menopausal women, the authors reported a 23% decline
(95% CL, 227.7%, 218.1%) in serum estradiol levels
among postmenopausal women who consumed 10% to 24%
of energy from fat over a period of 3 weeks to 5 months.8
However, the validity of this meta-analysis was compro-
mised by the validity of the component studies. None of the
four component studies included a simultaneous control
group.25-28 In addition, in three of the four studies, women
experienced statistically significant weight loss,25,27,28 and a
strong positive association between adiposity and post-
menopausal estrogen levels has been well document-
ed.16,29,30
Although small losses in weight are often seen in short-
term studies of dietary fat reduction, they are not sustained
in longer-term studies.31 Thus, studies that last for only a
few weeks or months may prompt misleading conclusions
about the long-term effects on blood hormone levels. In our
present analysis, we found that control for measures of
obesity caused a reversal in the associations seen.
Although not included in the meta-analysis because it
was conducted among women with breast cancer, one
randomized trial among postmenopausal women has been
reported. Rose et al32 reported a significant reduction in
serum estradiol levels among women with initially higher
levels, after an 18-month low-fat diet intervention. How-
ever, as described elsewhere,18 the comparisons in this
analysis were within the intervention group, not between the
intervention and control groups. In addition, women with
the lowest initial estradiol levels were excluded, leaving the
reduction to be seen only among women with initially high
levels. Because a similar reduction in estradiol levels was
seen in the control group, the results are consistent with
regression toward the mean and no effect of dietary fat.
In addition to intervention studies, several cross-sectional
studies have examined the relationship between low-fat diet
and plasma estrogens. In one of the largest of these, with
325 perimenopausal women, London et al33 reported no
association between fat intake and serum estrogen levels.
Likewise, a cross-sectional study of 253 postmenopausal
women in Wisconsin showed no association between fat
intake and serum estrone level.34 In another cross-sectional
study of 88 Greek women, no association was noted
between fat intake and urinary estrogen levels.35 However,
in two cross-sectional studies that included 24 and 93
women, respectively, vegetarian women who consumed a
low-fat diet were compared with nonvegetarian women who
consumed a higher-fat diet. Both found statistically signif-
icantly lower serum or urinary estrogen levels among the
vegetarians.36,37 However, in both of these studies, vegetar-
ian women were less obese than nonvegetarian women, and
the groups had many dietary differences other than fat
intake. In the larger of these two studies, the study by
Armstrong et al,36 adjustment for body mass index dimin-
ished the difference in urinary estrogens between vegetarian
and nonvegetarian women, although it was still statistically
significant; the smaller of these two studies, by Barbosa et
al,37 did not adjust for obesity at all. In addition, Barbosa et
al report a statistically significantly higher intake of fiber
among the vegetarian women, but they did not adjust for it
in the analysis,37 even though fiber intake has been hypoth-
esized to lower estrogen levels.38
Little has been written about the effect of low-fat diet on
hormones other than estrogens. Breast cancer risk has been
positively associated with androgens.16,39 Of the interven-
tions previously mentioned, only one, that by Ingram et al,28
examined the effect of a low-fat diet on serum androgens
among postmenopausal women. A nonsignificant decrease
in testosterone level and essentially no change in DHEAS
level were reported.28 Both this study and the intervention
by Prentice et al27 report a nonsignificant decrease in SHBG
level with low-fat dietary intervention. The cross-sectional
study from Wisconsin showed no association of dietary fat
intake with serum androgen or SHBG levels.34 In the two
cross-sectional studies that compared vegetarian women
with nonvegetarian women, one reported no significant
differences in plasma testosterone levels,36 the other no
significant difference in DHEAS levels,37 and both no
statistically significant difference in SHBG levels.
Very few cross-sectional studies have examined the
correlation between specific types of dietary fat and endog-
enous sex steroid hormones in postmenopausal women.
London et al33 reported no association between serum
estrogens and either saturated fat or linoleic acid. Likewise,
Katsouyanni et al35 report no association between urinary
estrogens and saturated, polyunsaturated, and monounsatu-
rated fats.
Use of diet records to validate the FFQ measure of fat
intake in this study has been criticized because of hypoth-
esized correlated error between the two self-reported mea-
sures of dietary intake.40 However, we used the same
analysis as in Table 3 to predict fasting serum triglyceride
levels, which are known to be inversely related to fat
intake,41 in 185 women. These women included 84 from the
sex steroid hormone analysis for whom we had triglyceride
levels, 41 who were diagnosed with breast cancer more than
2 years after dietary assessment, and 60 who were controls
in a study of myocardial infarction. All were postmeno-
pausal, nondiabetic, not taking cholesterol-lowering drugs,
and had fasted overnight. Controlling for fiber intake and
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the covariates listed in Table 3, we found the geometric
mean serum triglyceride levels (mg/dL) across categories of
percentage of energy from fat intake to be as follows: 156,
139, 129, 103, 85, and 70 mg/dL, corresponding to # 20%,
20.1% to 25%, 25.1% to 30%, 30.1% to 35%, 35.1% to
40%, and greater than 40% of kilocalories. These results are
comparable to those found in an intervention study among
hypercholesterolemic men by Knopp et al.42 That study
used diet records to measure reported fat intake among four
intervention groups with progressively lower fat intakes.
After 1 year of the interventions in which mean percentage
of energy from fat was 27%, 26%, 25%, and 22%, the
corresponding serum triglyceride levels increased by 10%,
3%, 22%, and 39%. Thus, our findings for plasma fasting
triglyceride levels provide clear objective evidence that the
dietary questions used in this study are sensitive to dietary
fat.
In summary, although a low-fat diet has been hypothe-
sized to reduce levels of endogenous sex hormones, previ-
ous intervention studies have been inconclusive because of
limitations in design or analysis. Our study was larger than
those of exclusively postmenopausal women and had the
advantage of averaging dietary intake over 4 to 5 years,
which reduced measurement error. Also, we were able to
extend the range of fat intake by oversampling women with
low fat intake and to cover multiple types of fat as well as
multiple hormones. We measured hormones with excellent
precision, having previously documented that a single
measure reasonably reflects average long-term hormone
levels.43 We were also able to control for potential con-
founding factors, such as obesity and alcohol intake.
Limitations of this study include its cross-sectional na-
ture. We were also limited in our ability to examine women
with extremely low fat intake, as only 15% of the total
population reported 20% or less of total energy from fat.
We found no evidence that higher fat intake is associated
with higher levels of any reproductive hormones in this group
of postmenopausal women. In fact, we found that the levels of
serum estradiol, a hormone associated with increased breast
cancer risk, were inversely associated with fat intake. Although
not consistently statistically significant, this inverse relation-
ship was true for most types of fat, including animal, vegetable,
saturated, monounsaturated, polyunsaturated, and omega-3
(from fish) fats; the exception was a nonsignificant positive
association with trans-unsaturated fat intake. These results are
consistent with our previous finding of a lack of association
between low intake of total fat over 14 years of follow-up and
a decreased risk of breast cancer.12 In addition, we found that
DHEA and DHEAS levels had a strong positive association
with monounsaturated fat intake and a strong inverse associa-
tion with polyunsaturated fat intake; these novel findings need
to be duplicated in other studies. Our findings suggest that
adoption of a low-fat diet during midlife does not lower
long-term endogenous estrogen levels, which has been the
hypothesized mechanism by which a low-fat diet might pre-
vent breast cancer.
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